Tigermed Clinical Research India Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 09-12-2024
- Paid Up Capital ₹ 1.04 M
as on 09-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 24.57%
(FY 2022)
- Profit 21.01%
(FY 2022)
- Ebitda 20.60%
(FY 2022)
- Net Worth 39.87%
(FY 2022)
- Total Assets 39.76%
(FY 2022)
About Tigermed Clinical Research India
The Corporate was formerly known as Tigermed India Data Solutions Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.04 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Mehra, Munish Mehra, Wen Zengyu, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900KA2016PTC085751
- Company No.
085751
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2016
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Tigermed Clinical Research India?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Mehra  | Director | 02-Feb-2016 | Current |
Wen Zengyu  | Director | 25-Jul-2016 | Current |
| Girish Mehra | Director | 02-Feb-2016 | Current |
| Huang Liling | Director | 03-Feb-2017 | Current |
| Kirti Bhatt | Director | 26-Jul-2024 | Current |
| Guangbin Peng | Director | 26-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Tigermed Clinical Research India.
Tigermed Clinical Research India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.57% increase. The company also saw a substantial improvement in profitability, with a 21.01% increase in profit. The company's net worth Soared by an impressive increase of 39.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tigermed Clinical Research India?
In 2021, Tigermed Clinical Research India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Credit Suisse Business Analytics (India) Private LimitedActive 15 years 10 monthsGirish Mehra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tigermed Clinical Research India?
Tigermed Clinical Research India has a workforce of 18 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tigermed Clinical Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tigermed Clinical Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
